Honduras vs Korea: Incidence of tuberculosis
Incidence of tuberculosis over time
- Honduras
- Korea
How they compare
Honduras currently reports 38 per 100,000 people against 35 per 100,000 people in Korea, a difference of 3 per 100,000 people.
That makes Honduras's figure about 1.1 times Korea's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Honduras ahead.
Honduras ranks 111th and Korea ranks 113th of 208 countries.
Across the 3 decades both report, Honduras averaged higher in 1 and Korea in 2.
Head to head by decade
| Decade | Honduras | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 126 per 100,000 people | 84.3 per 100,000 people | 41.7 per 100,000 people | Honduras |
| 2010s | 51.7 per 100,000 people | 81.3 per 100,000 people | 29.6 per 100,000 people | Korea |
| 2020s | 38 per 100,000 people | 41 per 100,000 people | 3 per 100,000 people | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Honduras or Korea?
- Honduras, at 38 per 100,000 people against 35 per 100,000 people in Korea as of 2024.
- What is the difference in incidence of tuberculosis between Honduras and Korea?
- 3 per 100,000 people, with Honduras ahead.
- How many years of comparable data are there for Honduras and Korea?
- 25 years are reported by both, from 2000 to 2024.
- How do Honduras and Korea rank globally for incidence of tuberculosis?
- Honduras ranks 111th and Korea ranks 113th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.